Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3490629010 | Product containing hydrochlorothiazide and irbesartan (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3715152014 | Hydrochlorothiazide- and irbesartan-containing product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 32621000188118 | médicament contenant irbesartan et hydrochlorothiazide | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing hydrochlorothiazide and irbesartan (medicinal product) | Is a | Product containing hydrochlorothiazide (medicinal product) | true | Inferred relationship | Some | ||
| Product containing hydrochlorothiazide and irbesartan (medicinal product) | Is a | Product containing irbesartan (medicinal product) | true | Inferred relationship | Some | ||
| Product containing hydrochlorothiazide and irbesartan (medicinal product) | Has active ingredient | Hydrochlorothiazide (substance) | true | Inferred relationship | Some | 2 | |
| Product containing hydrochlorothiazide and irbesartan (medicinal product) | Has active ingredient | Irbesartan (substance) | true | Inferred relationship | Some | 1 | |
| Product containing hydrochlorothiazide and irbesartan (medicinal product) | Is a | Angiotensin II receptor antagonist+diuretic | false | Inferred relationship | Some | ||
| Product containing hydrochlorothiazide and irbesartan (medicinal product) | Plays role | Diuretic therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) | Is a | False | Product containing hydrochlorothiazide and irbesartan (medicinal product) | Inferred relationship | Some | |
| Hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet | Is a | False | Product containing hydrochlorothiazide and irbesartan (medicinal product) | Inferred relationship | Some | |
| Hydrochlorothiazide- and irbesartan-containing product in oral dose form | Is a | True | Product containing hydrochlorothiazide and irbesartan (medicinal product) | Inferred relationship | Some | |
| Hydrochlorothiazide and irbesartan only product | Is a | True | Product containing hydrochlorothiazide and irbesartan (medicinal product) | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
FHIR